Descovy 200 mg/25 mg (emtricitabine and tenofovir alafenamide) tablet
Descovy 200 mg/25 mg (emtricitabine and tenofovir alafenamide) tablet
Quantity
Get it to United States within 10 working days with standard delivery.
Fast delivery to United States
Easy Returns & Exchanges
Ask About This Product
Condition : New
0
From UAE
To United States
in 5-10 days
Description
How It Works
Descovy is a combination medication containing two active ingredients: emtricitabine and tenofovir alafenamide. Emtricitabine and tenofovir alafenamide are both nucleoside reverse transcriptase inhibitors (NRTIs) that work by interfering with the action of an enzyme called reverse transcriptase, which is essential for the replication of the human immunodeficiency virus (HIV). By inhibiting reverse transcriptase, Descovy helps to reduce the amount of HIV in the body and improve immune function.Side Effects
- Nausea
- Diarrhea
- Headache
- Fatigue
- Dizziness
Indications
- Descovy is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg in combination with other antiretroviral agents.
- It is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg.
Contraindications
- Hypersensitivity to emtricitabine, tenofovir alafenamide, or any component of the formulation
- Co-administration with dofetilide
Price Comparison in Different Countries
| Country | Price (per unit) | References |
|---|---|---|
| United States | $1,800 | GoodRx |
| United Kingdom | ?1,500 | NHS |
| Australia | AUD 2,500 | PBS Australia |
| Canada | CAD 2,800 | CADTH |
| Germany | ?2,000 | Apotheken Umschau |
Top 5 Global Brands
- Pfizer
- Roche
- Novartis
- Merck & Co.
- Johnson & Johnson